CAS RN: 1682653-80-0

Tetrazine-PEG5-NHS ester

Product Availability

Choose a grade to view its available package options.

6 package records5 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260115 1g Out of stock 15 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260121 100mg In stock Shanghai Inquiry
Batchno.20250414 10mg In stock Shanghai Inquiry
Batchno.20260207 250mg In stock Shanghai Inquiry
Batchno.20260130 25mg In stock Shanghai Inquiry
Batchno.20250626 50mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1682653-80-0
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1682653-80-0 / (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[3-oxo-3-[[4-(1,2,4,5-tetrazin-3-yl)phenyl]methylamino]propoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate

Standard CAS: 1682653-80-0 Multi CAS: No

Basic Information

CAS
1682653-80-0
Multi CAS
No
Molecular Formula
C27H36N6O10
Molecular Weight
604.600000
Exact Mass
604.249291
SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCC(=O)NCC2=CC=C(C=C2)C3=NN=CN=N3
InChI
InChI=1S/C27H36N6O10/c34-23(28-19-21-1-3-22(4-2-21)27-31-29-20-30-32-27)7-9-38-11-13-40-15-17-42-18-16-41-14-12-39-10-8-26(37)43-33-24(35)5-6-25(33)36/h1-4,20H,5-19H2,(H,28,34)
InChIKey
DUPHIQYIPUTDJS-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
43
Aromatic heavy atom count
12
Fraction Csp3
0.56
Rotatable bonds
22
H-bond acceptors
14
H-bond donors
1
Molar refractivity
145.41
TPSA
190.49

LogP / Solubility

WLOGP
0.02
MLOGP
0.07
XLogP3
-2.5
Consensus LogP
-0.8
Log S (ESOL)
-2.36
Class (ESOL)
Moderately soluble
Log S (Ali)
-4.53
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6.25
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.39

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
4

Get In Touch

Contact Us